In a filing, Catalyst Pharmaceuticals Inc revealed its Director Tierney David S unloaded Company’s shares for reported $0.3 million on Aug 21 ’24. In the deal valued at $20.10 per share,15,000 shares were sold. As a result of this transaction, Tierney David S now holds 348,874 shares worth roughly $6.89 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Miller Steve sold 150,000 shares, generating $3,052,900 in total proceeds. Upon selling the shares at $20.35, the Chief Op. & Scientific Officer now owns 675,124 shares.
Before that, Tierney David S bought 15,000 shares. Catalyst Pharmaceuticals Inc shares valued at $301,450 were divested by the Director at a price of $20.10 per share.
Citigroup initiated its Catalyst Pharmaceuticals Inc [CPRX] rating to a Buy in a research note published on March 14, 2024; the price target was $27. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Oppenheimer began covering CPRX with “an Outperform” recommendation on December 21, 2023. ROTH Capital revised its rating on August 24, 2022. It rated CPRX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CPRX
On Tuesday, Catalyst Pharmaceuticals Inc [NASDAQ:CPRX] saw its stock fall -2.52% to $19.74. Over the last five days, the stock has lost -3.94%. Catalyst Pharmaceuticals Inc shares have risen nearly 17.43% since the year began. Nevertheless, the stocks have risen 40.60% over the past one year. While a 52-week high of $20.87 was reached on 08/22/24, a 52-week low of $11.55 was recorded on 02/08/24. SMA at 50 days reached $17.61, while 200 days put it at $15.79.
Levels Of Support And Resistance For CPRX Stock
The 24-hour chart illustrates a support level at 19.53, which if violated will result in even more drops to 19.31. On the upside, there is a resistance level at 20.16. A further resistance level may holdings at 20.58. The Relative Strength Index (RSI) on the 14-day chart is 56.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.89%. Stochastics %K at 53.94% indicates the stock is a holding.
How much short interest is there in Catalyst Pharmaceuticals Inc?
A steep rise in short interest was recorded in Catalyst Pharmaceuticals Inc stocks on 2024-08-15, dropping by -0.29 million shares to a total of 5.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 5.35 million shares. There was a decline of -5.77%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 21, 2018 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
